New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
PSMA PET imaging improves accuracy of predicting prostate cancer recurrence

PSMA PET imaging improves accuracy of predicting prostate cancer recurrence

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainA molecular imaging tool developed by researchers at the University of California's two nationally ranked medical cen
World medicine December 05,2023
PSMA PET imaging improves accuracy of predicting prostate cancer recurrence

PSMA PET imaging improves accuracy of predicting prostate cancer recurrence

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainA molecular imaging tool developed by researchers at the University of California's two nationally ranked medical cen
World medicine December 05,2023
PROSPECT trial expands treatment options for patients with resectable rectal cancer

PROSPECT trial expands treatment options for patients with resectable rectal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainThe American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statem
World medicine December 05,2023
PROSPECT trial expands treatment options for patients with resectable rectal cancer

PROSPECT trial expands treatment options for patients with resectable rectal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainThe American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statem
World medicine December 05,2023
Some patients with small-cell lung cancer can benefit from PARP inhibitor with immune checkpoint blockade

Some patients with small-cell lung cancer can benefit from PARP inhibitor with immune checkpoint blockade

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAmong patients with extensive stage small-cell lung cancer (SCLC) that is positive for expression of the Schlafen-11 gene (SLFN11), thos
World medicine December 05,2023
Some patients with small-cell lung cancer can benefit from PARP inhibitor with immune checkpoint blockade

Some patients with small-cell lung cancer can benefit from PARP inhibitor with immune checkpoint blockade

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAmong patients with extensive stage small-cell lung cancer (SCLC) that is positive for expression of the Schlafen-11 gene (SLFN11), thos
World medicine December 05,2023
NCCN addresses ongoing chemotherapy shortages: More than 90% of cancer centers are impacted

NCCN addresses ongoing chemotherapy shortages: More than 90% of cancer centers are impacted

by National Comprehensive Cancer NetworkPlease indicate if there are other drugs in short supply at your center. Credit:Carboplatin & Cisplatin Shortage(2023)The National Comprehensive
World medicine December 05,2023
NCCN addresses ongoing chemotherapy shortages: More than 90% of cancer centers are impacted

NCCN addresses ongoing chemotherapy shortages: More than 90% of cancer centers are impacted

by National Comprehensive Cancer NetworkPlease indicate if there are other drugs in short supply at your center. Credit:Carboplatin & Cisplatin Shortage(2023)The National Comprehensive
World medicine December 05,2023
MYC inhibition in melanoma: Preclinical promise and the unveiling of a prognostic gene signature

MYC inhibition in melanoma: Preclinical promise and the unveiling of a prognostic gene signature

by Vall d'Hebron Institute of OncologyOmomyc induces growth arrest in melanoma human cell lines in vitro. (A) Growth inhibition by transgenic Omomyc at 10 d by Crystal Violet staining. (B) Early e
World medicine December 05,2023
MYC inhibition in melanoma: Preclinical promise and the unveiling of a prognostic gene signature

MYC inhibition in melanoma: Preclinical promise and the unveiling of a prognostic gene signature

by Vall d'Hebron Institute of OncologyOmomyc induces growth arrest in melanoma human cell lines in vitro. (A) Growth inhibition by transgenic Omomyc at 10 d by Crystal Violet staining. (B) Early e
World medicine December 05,2023
Elevated MRI enhancement helps indicate cancer risk in women with very dense breasts

Elevated MRI enhancement helps indicate cancer risk in women with very dense breasts

byRadiological Society of North AmericaRepresentative transverse dynamic contrast-enhanced MRI scans in patients in the low and high tertiles of volume of enhancing parenchyma. Please note diffe
World medicine December 05,2023
Elevated MRI enhancement helps indicate cancer risk in women with very dense breasts

Elevated MRI enhancement helps indicate cancer risk in women with very dense breasts

byRadiological Society of North AmericaRepresentative transverse dynamic contrast-enhanced MRI scans in patients in the low and high tertiles of volume of enhancing parenchyma. Please note diffe
World medicine December 05,2023
MRI scans improve prostate cancer diagnosis in screening trial

MRI scans improve prostate cancer diagnosis in screening trial

byUniversity College LondonCredit: CC0 Public DomainThe REIMAGINE study, published today inBMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to
World medicine December 05,2023
MRI scans improve prostate cancer diagnosis in screening trial

MRI scans improve prostate cancer diagnosis in screening trial

byUniversity College LondonCredit: CC0 Public DomainThe REIMAGINE study, published today inBMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to
World medicine December 05,2023
LY6 gene family: Potential tumor antigens and prognostic biomarkers in endometrial cancer

LY6 gene family: Potential tumor antigens and prognostic biomarkers in endometrial cancer

by Impact Journals LLCComparison of human LY6 gene expression in normal uterine tissue (n = 146) to expression in uterine corpus endometrial carcinoma (n = 547). Credit: 2023 Rathbun et al.A new resea
World medicine December 05,2023
LY6 gene family: Potential tumor antigens and prognostic biomarkers in endometrial cancer

LY6 gene family: Potential tumor antigens and prognostic biomarkers in endometrial cancer

by Impact Journals LLCComparison of human LY6 gene expression in normal uterine tissue (n = 146) to expression in uterine corpus endometrial carcinoma (n = 547). Credit: 2023 Rathbun et al.A new resea
World medicine December 05,2023
LP-284 targets non-Hodgkin's lymphoma and DNA damage repair deficiency

LP-284 targets non-Hodgkin's lymphoma and DNA damage repair deficiency

by Impact Journals LLCFigure 6: LP-284 is selectively lethal in cells with TC-NER deficiency. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28454A new research paper titled "LP-28
World medicine December 05,2023
LP-284 targets non-Hodgkin's lymphoma and DNA damage repair deficiency

LP-284 targets non-Hodgkin's lymphoma and DNA damage repair deficiency

by Impact Journals LLCFigure 6: LP-284 is selectively lethal in cells with TC-NER deficiency. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28454A new research paper titled "LP-28
World medicine December 05,2023
Living well with advanced cancer

Living well with advanced cancer

by Jennifer Philip,University of MelbourneCredit: Unsplash/CC0 Public DomainWhile many of us may benefit from the extraordinary advances being made in cancer care, there are still about 45,000 A
World medicine December 05,2023
Living well with advanced cancer

Living well with advanced cancer

by Jennifer Philip,University of MelbourneCredit: Unsplash/CC0 Public DomainWhile many of us may benefit from the extraordinary advances being made in cancer care, there are still about 45,000 A
World medicine December 05,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com